EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access

Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review

Kentaro Suda, Noriko Kimura, Toshihiro Maeda, Shiro Watanabe, Sachiyo Nishida, Hiroaki Shima, Taro Sugawara, Shinya Uchino, Aki Ishikawa, Toshiaki Tanaka, Masato Furuhashi, Naoya Masumori und 1 weitere

Endocrine Journal · 2026 · 73 (7) · 889-897

DOI: 10.1507/endocrj.ej25-0486 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrine Journal, 2026. Verfasst von Kentaro Suda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Genomics, Department of Genomic and Preventive Medicine, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan. Hauptthemen laut MEDLINE: Pheochromocytoma, 3-Iodobenzylguanidine, Adrenal Gland Neoplasms, Multiple Endocrine Neoplasia Type 2a. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pheochromocytoma3-IodobenzylguanidineAdrenal Gland NeoplasmsMultiple Endocrine Neoplasia Type 2aThyroid NeoplasmsIodine RadioisotopesCarcinoma, NeuroendocrineHumansFemaleMiddle AgedProto-Oncogene Proteins c-retThyroidectomyAdrenalectomy

Stichwörter der Autor:innen

Iodine-131-metaiodobenzylguanidine therapyMetastatic pheochromocytomaMultiple endocrine neoplasia type 2

Substanzen

3-IodobenzylguanidineIodine RadioisotopesProto-Oncogene Proteins c-retIodine-131

Autor:innen und Institutionen

  • Division of Clinical Genomics, Department of Genomic and Preventive Medicine, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
  • Department of Diagnostic Pathology, National Hospital Organization Hakodate Medical Center, Hakodate 041-8512, Japan.
  • Department of Urology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
  • Department of Nuclear Medicine, Hokkaido University Hospital, Sapporo 060-8648, Japan.
  • Department of Surgery, Surgical Oncology and Science, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
  • Department of Surgical Pathology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.

Zitieren

APA

Suda, K., Kimura, N., Maeda, T., Watanabe, S., Nishida, S., Shima, H., Sugawara, T., Uchino, S., Ishikawa, A., Tanaka, T., Furuhashi, M., Masumori, N., & Sakurai, A. (2026). Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review. Endocrine Journal, 73(7), 889-897. https://doi.org/10.1507/endocrj.ej25-0486

Vancouver

Suda K, Kimura N, Maeda T, Watanabe S, Nishida S, Shima H, et al. Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review. Endocrine Journal. 2026;73(7):889-897. doi:10.1507/endocrj.ej25-0486

BibTeX
@article{Suda2026,
  author = {Suda, Kentaro and Kimura, Noriko and Maeda, Toshihiro and Watanabe, Shiro and Nishida, Sachiyo and Shima, Hiroaki and Sugawara, Taro and Uchino, Shinya and Ishikawa, Aki and Tanaka, Toshiaki and Furuhashi, Masato and Masumori, Naoya and Sakurai, Akihiro},
  title = {Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review},
  journal = {Endocrine Journal},
  year = {2026},
  volume = {73},
  number = {7},
  pages = {889--897},
  doi = {10.1507/endocrj.ej25-0486}
}
Kostenlos starten →